Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

VERU vs SIGA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VERU Captures Overall Composite Edge (62.8 BUY vs 47.5 HOLD), While SIGA Leads 4–2 on Growth & Valuation Pillars

VERU Overall Winner 6-Pillar Tally: VERU 2 – 4 SIGA Matrix Metrics: VERU 5 – 5 SIGA

As of Nov 19, 2026, Veru Inc. (VERU) captures the overall head-to-head institutional edge over SIGA Technologies Inc. (SIGA) on higher Unified Composite conviction (62.8/100 BUY vs. 47.5/100 HOLD) after splitting the core matrix 5–5 (led by Growth & Scale, Profitability & Quality), while SIGA wins 4–2 across the 6-pillar growth and valuation breakdown. VERU trades at $2.11 (117.7x Forward P/E, 0.0% operating margin) versus SIGA at $2.65 (2.5x Forward P/E, -14.2% operating margin).

  • Growth vs. Quality Trade-Off: VERU earns the overall head-to-head edge with a stronger Unified Composite Score (62.8/100 BUY vs. SIGA 47.5/100 HOLD) and 1.78β · 53% Vol risk profile, whereas SIGA leads top-line expansion (-49.7% YoY revenue growth, 3.37x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: VERU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VERU vs SIGA
VERU NASDAQ Head-to-Head Winner
Veru Inc.
Pharmaceutical Preparations
$2.11
-8.66% 1D
Market Cap $36.4M
TTM Revenue $17M
Forward P/E 117.7x
Beta / 30D Vol 1.78β · 53% Vol
Unified Composite Score
62.8 / 100 BUY
Tech 56.0 Fund 54.0 Flow 72.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 44
RSI-14: 44.1 · SMA20: $2.17 · SMA50: $2.32
SIGA NASDAQ
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.65
-5.36% 1D
Market Cap $187.9M
TTM Revenue $52M
Forward P/E 2.5x
Beta / 30D Vol 0.75β · 65% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.6%), weak momentum, RSI 37
RSI-14: 36.7 · SMA20: $3.02 · SMA50: $3.14

6-Pillar Scorecard Institutional Category Breakdown (VERU 2 – 4 SIGA)

Columns: Metric · VERU · SIGA
1. Valuation Multiples SIGA
Forward P/E 117.7x 2.5x
Trailing P/E 117.7x N/M
PEG Ratio 3.60x 3.37x
EV / Revenue 0.9x 1.4x
2. Growth & Scale VERU
Revenue Growth (YoY) +18.3% -49.7%
Earnings Growth (YoY) +0.0% -65.3%
TTM Revenue (USD) $17M $52M
Market Cap $36.4M $187.9M
3. Profitability & Quality VERU
Gross Margin 34.7% 23.4%
Operating Margin 0.0% -14.2%
Net Profit Margin 0.0% 1.3%
Return on Equity (ROE) -64.5% 0.4%
4. Balance Sheet & Cash Flow SIGA
Cash Generation (TTM) -$26M -$12M
Cash Flow Margin N/A -22.1%
Net Cash / Leverage $21M Net Cash $116M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SIGA
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 74.7% (10th %ile) 81.4% (8th %ile)
Put/Call OI Skew N/A 0.04x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat SIGA
OpEx & R&D Intensity 34.7% of Rev ($5.9M) 37.6% of Rev ($20M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VERU (5) vs SIGA (5)
Institutional Metric VERU SIGA Criterion Row Edge
Market Capitalization
Scale
$36.4M $187.9M Larger Scale SIGA
Trailing P/E Ratio
Valuation
117.7x N/M Lower Multiple VERU
Forward P/E Ratio
Valuation
117.7x 2.5x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
+18.3% -49.7% Higher Growth VERU
Operating Margin (TTM)
Profitability
0.0% -14.2% Higher Margin VERU
Net Profit Margin
Profitability
0.0% 1.3% Higher Margin SIGA
Return on Equity (ROE)
Capital Efficiency
-64.5% 0.4% Higher ROE SIGA
52-Week Range Position
Momentum
2% ($2–$7) 3% ($3–$7) Stronger Trend SIGA
Beta / 30D Volatility
Risk Regime
1.78β · 53% Vol 0.75β · 65% Vol Lower Realized Risk VERU
Unified Institutional Score
Composite Signal
62.8 / 100 (BUY) 47.5 / 100 (HOLD) Higher Composite VERU
Trailing 12M Revenue (USD)
Operating Scale
$17M $52M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.7% 23.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.60x PEG · 0.9x EV/Rev 3.37x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$26M ($21M Net Cash) -$12M ($116M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VERU +6.8 pp
VERU: -8.26% · SIGA: -15.06%
3M Horizon SIGA +7.25 pp
VERU: -20.08% · SIGA: -12.83%
6M Horizon VERU +38.79 pp
VERU: -4.95% · SIGA: -43.74%
1Y Horizon VERU +39.01 pp
VERU: -16.6% · SIGA: -55.61%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VERU Revenue SIGA Revenue VERU Op. Margin SIGA Op. Margin Margin Leader
FY2018 $20M $480M -131.6% 74.4% SIGA
FY2019 $30M $30M -20.2% -8.7% SIGA
FY2020 $40M $120M -34.6% 67.6% SIGA
FY2021 $60M $130M 21.2% 66.7% SIGA
FY2022 $40M $110M -212.1% 38.5% SIGA
FY2023 $20M $140M -575.5% 59.8% SIGA
FY2024 $20M $140M -214.2% 50.4% SIGA
FY2025 N/A $90M N/A 25.1% SIGA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VERU BREAKDOWN
117d in phase · OBV NEUTRAL
Current IV 74.7%
IV Percentile 10th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VERU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SIGA CONSOLIDATION
33d in phase · OBV DISTRIBUTION
Current IV 81.4%
IV Percentile 8th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VERU Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $36.4M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment 34.7% of Rev ($5.9M)
90D Engineering Disclosures 0 Published
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $187.9M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published

Investor FAQ VERU vs SIGA Key Questions & Quantitative Answers

As of Nov 19, 2026, Veru Inc. (VERU) captures the overall head-to-head institutional edge over SIGA Technologies Inc. (SIGA) on higher Unified Composite conviction (62.8/100 BUY vs. 47.5/100 HOLD) after splitting the core matrix 5–5 (led by Growth & Scale, Profitability & Quality), while SIGA wins 4–2 across the 6-pillar growth and valuation breakdown. VERU trades at $2.11 (117.7x Forward P/E, 0.0% operating margin) versus SIGA at $2.65 (2.5x Forward P/E, -14.2% operating margin). Growth vs. Quality Trade-Off: VERU earns the overall head-to-head edge with a stronger Unified Composite Score (62.8/100 BUY vs. SIGA 47.5/100 HOLD) and 1.78β · 53% Vol risk profile, whereas SIGA leads top-line expansion (-49.7% YoY revenue growth, 3.37x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: VERU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VERU leads the Growth & Scale pillar: VERU posts +18.3% YoY revenue growth and +0.0% YoY earnings growth on $17M TTM revenue (34.7% gross margin, 0.0% operating margin), compared with SIGA at -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), VERU cumulative revenue shifted +0.0% while SIGA shifted -81.2%. In operating R&D and SG&A reinvestment, VERU deploys 34.7% of Rev ($5.9M) (0 90-day corporate R&D disclosures) versus 37.6% of Rev ($20M) (0 disclosures) for SIGA.

SIGA screens cheaper on headline valuation multiples. VERU trades at 117.7x Forward P/E, 117.7x Trailing P/E, 3.60x PEG, and 0.9x EV/Revenue (unreported FCF margin), whereas SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VERU (-64.5% ROE) versus SIGA (0.4% ROE) capital efficiency.

In options market volatility and institutional positioning, VERU carries 74.7% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.78β · 53% Vol realized risk). By comparison, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.